First Time Loading...
N

Neuca SA
WSE:NEU

Watchlist Manager
Neuca SA
WSE:NEU
Watchlist
Price: 945 PLN 0.75%
Updated: May 15, 2024
Section:
 

Relative Value

The Relative Value of one NEU stock under the Base Case scenario is 2 389.82 PLN. Compared to the current market price of 945 PLN, Neuca SA is Undervalued by 60%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NEU Relative Value
Base Case
2 389.82 PLN
Undervaluation 60%
Relative Value
Price
N
Worst Case
Base Case
Best Case

Valuation Multiples

0.4
P/S
P/S
Price to Sales
0.4
vs History
12
vs Industry
83
Median 3Y
0.3
Median 5Y
0.3
Industry
2.4
Forward
0.3
More Details
28.5
P/E
P/E
Price to Earnings
28.5
vs History
4
vs Industry
21
Median 3Y
23.9
Median 5Y
20.7
Industry
23.9
Forward
19.2
More Details
14.5
P/OCF
P/OCF
Price to OCF
14.5
vs History
4
vs Industry
29
Median 3Y
10.3
Median 5Y
9.5
Industry
15.6
More Details
50.4
P/FCFE
P/FCFE
Price to FCFE
50.4
vs History
9
vs Industry
12
Median 3Y
14.9
Median 5Y
12.3
Industry
22.5
More Details
4.2
P/B
P/B
Price to Book Value
4.2
vs History
9
vs Industry
21
Median 3Y
3.8
Median 5Y
3.5
Industry
2.3
More Details
0.4
EV/S
EV/S
Enterprise Value to Sales
0.4
vs History
12
vs Industry
83
Median 3Y
0.3
Median 5Y
0.3
Industry
2.5
Forward
0.3
More Details
3.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.3
vs History
19
vs Industry
58
Median 3Y
3.1
Median 5Y
2.7
Industry
5.3
More Details
11.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.5
vs History
15
vs Industry
31
Median 3Y
10.9
Median 5Y
9.9
Industry
12.9
Forward
9.5
More Details
16.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.4
vs History
14
vs Industry
29
Median 3Y
15.5
Median 5Y
13.4
Industry
17.8
Forward
13.4
More Details
15.1
EV/OCF
EV/OCF
Enterprise Value to OCF
15.1
vs History
4
vs Industry
30
Median 3Y
11
Median 5Y
9.9
Industry
15.4
More Details
22.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
22.5
vs History
9
vs Industry
22
Median 3Y
13.8
Median 5Y
13.8
Industry
19.6
More Details
2.4
EV/IC
EV/IC
Enterprise Value to IC
2.4
vs History
15
vs Industry
33
Median 3Y
2.3
Median 5Y
2
Industry
2
More Details

Multiples Across Competitors

NEU Competitors Multiples
Neuca SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
PL
Neuca SA
WSE:NEU
4.2B PLN 0.4 28.5 11.5 16.4
US
Mckesson Corp
NYSE:MCK
71.7B USD 0.2 23.9 15.9 18.5
US
Cencora Inc
NYSE:COR
44.3B USD 0.2 23.9 11.8 16.4
US
Amerisourcebergen Corp
NYSE:ABC
35.4B USD 0.1 20.9 11.3 15.2
US
Cardinal Health Inc
NYSE:CAH
23.8B USD 0.1 43.1 8.8 11.8
US
Henry Schein Inc
NASDAQ:HSIC
9.3B USD 0.8 24.1 12.3 17.3
CN
Sinopharm Group Co Ltd
HKEX:1099
70.4B HKD 0.1 7.3 1.8 2.2
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
IT
Amplifon SpA
MIL:AMP
7.7B EUR 3.4 49.4 15.8 31.2
CN
Huadong Medicine Co Ltd
SZSE:000963
58.8B CNY 1.4 20 15.2 15.2
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
53.7B CNY 0.2 14.2 8.3 8.3

See Also

Summary
NEU intrinsic value, competitors valuation, and company profile.
DCF Valuation
NEU stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NEU stock valuation using valuation multiples.
Wall Street Estimates
NEU price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NEU stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.